WT2
MCID: WLM005
MIFTS: 27

Wilms Tumor 2 (WT2)

Categories: Blood diseases, Cancer diseases, Fetal diseases, Genetic diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Wilms Tumor 2

MalaCards integrated aliases for Wilms Tumor 2:

Name: Wilms Tumor 2 57 29 13 6 72
Wilms Tumor, Type 2 40
Wt2 57

Characteristics:

OMIM:

57
Inheritance:
somatic mutation
autosomal dominant

Miscellaneous:
most case are sporadic


HPO:

32

Classifications:



External Ids:

MedGen 42 C3887743
UMLS 72 C3887743

Summaries for Wilms Tumor 2

MalaCards based summary : Wilms Tumor 2, also known as wilms tumor, type 2, is related to wilms tumor 1 and familial wilms tumor 2. An important gene associated with Wilms Tumor 2 is H19 (H19 Imprinted Maternally Expressed Transcript). The drugs Vincristine and Dactinomycin have been mentioned in the context of this disorder. Affiliated tissues include liver, and related phenotype is nephroblastoma.

More information from OMIM: 194071 PS194070

Related Diseases for Wilms Tumor 2

Diseases in the Hereditary Wilms' Tumor family:

Wilms Tumor 1 Wilms Tumor 2
Wilms Tumor 3 Wilms Tumor 4
Wilms Tumor 5 Wilms Tumor 6
Familial Wilms Tumor 2

Diseases related to Wilms Tumor 2 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 wilms tumor 1 28.5 KCNQ1DN H19
2 familial wilms tumor 2 12.4
3 wilms tumor predisposition 11.3
4 aniridia 1 9.8
5 wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome 9.8
6 wilms tumor 5 9.8

Graphical network of the top 20 diseases related to Wilms Tumor 2:



Diseases related to Wilms Tumor 2

Symptoms & Phenotypes for Wilms Tumor 2

Human phenotypes related to Wilms Tumor 2:

32
# Description HPO Frequency HPO Source Accession
1 nephroblastoma 32 HP:0002667

Symptoms via clinical synopsis from OMIM:

57
Genitourinary Kidneys:
nephroblastoma (wilms tumor)

Neoplasia:
nephroblastoma (wilms tumor)

Clinical features from OMIM:

194071

Drugs & Therapeutics for Wilms Tumor 2

Drugs for Wilms Tumor 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
2
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
3
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
4 Tubulin Modulators Phase 3
5
Liposomal doxorubicin Phase 3 31703
6 Antineoplastic Agents, Phytogenic Phase 3
7 Anti-Bacterial Agents Phase 3
8 Antibiotics, Antitubercular Phase 3
9 Anti-Infective Agents Phase 3
10 Topoisomerase Inhibitors Phase 3
11 Nucleic Acid Synthesis Inhibitors Phase 3
12 Antimitotic Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor Completed NCT00352534 Phase 3 vincristine sulfate;doxorubicin hydrochloride

Search NIH Clinical Center for Wilms Tumor 2

Genetic Tests for Wilms Tumor 2

Genetic tests related to Wilms Tumor 2:

# Genetic test Affiliating Genes
1 Wilms Tumor 2 29 H19

Anatomical Context for Wilms Tumor 2

MalaCards organs/tissues related to Wilms Tumor 2:

41
Liver

Publications for Wilms Tumor 2

Articles related to Wilms Tumor 2:

(show all 25)
# Title Authors PMID Year
1
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. 8 71
18836444 2008
2
Wilms Tumor Predisposition 71
20301471 2003
3
Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. 8
1656527 1991
4
Constitutional and somatic deletions of two different regions of maternal chromosome 11 in Wilms tumor. 8
1973142 1990
5
Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. 8
2163053 1990
6
Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. 8
2566168 1989
7
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. 8
2539717 1989
8
Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. 8
2542777 1989
9
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. 8
2848758 1988
10
Phenotype evolution and health issues of adults with Beckwith-Wiedemann syndrome. 38
31339634 2019
11
Long-term physiologic and oncologic outcomes of inferior vena cava thrombosis in pediatric malignant abdominal tumors. 38
25840061 2015
12
Second malignancies after autologous hematopoietic cell transplantation in children. 38
22964594 2013
13
Identification of ovarian genes regulated by follicle-stimulating hormone (Fsh) in vitro during early secondary oocyte growth in coho salmon. 38
23200633 2013
14
Liver lesions in children and adolescents: cytopathologic analysis and clinical correlates in 44 cases. 38
21309009 2012
15
Early experience with PET/CT scan in the evaluation of pediatric abdominal neoplasms. 38
19040932 2008
16
Immunohistochemical analysis of gamma catenin in Wilms' tumors. 38
18568994 2008
17
Thymic and adenotonsillar enlargement after successful treatment of malignancies. 38
16020133 2005
18
Metachronous Wilms tumor associated with pulmonary embolism: how can we detect these cases early? A case report and literature review. 38
12687754 2003
19
Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor. 38
10918395 2000
20
Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines. 38
9290704 1997
21
[Aniridia and Wilms tumor: 2 cases of fetal rhabdomyomatous nephroblastoma]. 38
9033789 1996
22
The role of spiral (helical) computerized tomography with three-dimensional reconstruction in pediatric solid tumors. 38
7738757 1995
23
The nephroblastomatosis complex and its relationship to Wilms' tumor. 38
2170616 1990
24
Mediastinal mass following chemotherapeutic treatment of Hodgkin's disease: recurrent tumor or thymic hyperplasia? 38
3440903 1987
25
Sarcomatous variants of Wilms' tumor. Immunohistochemical and ultrastructural comparison with classical Wilms' tumor. 38
2434203 1987

Variations for Wilms Tumor 2

ClinVar genetic disease variations for Wilms Tumor 2:

6
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 H19 H19, 5.3-KB DEL deletion Pathogenic
2 H19 H19, 1.43-KB TRIPLICATION undetermined variant Pathogenic
3 H19 ; H19-ICR ; ICR1 ; MRPL23 NR_002196.1(H19): n.-7080_-1781del deletion Pathogenic
4 H19 ; H19-ICR ; ICR1 ; MRPL23 GRCh38/hg38 11p15.5(chr11: 2000799-2001783)x3 copy number gain Pathogenic 11:2022018-2023452 11:2000788-2002222

Expression for Wilms Tumor 2

Search GEO for disease gene expression data for Wilms Tumor 2.

Pathways for Wilms Tumor 2

GO Terms for Wilms Tumor 2

Sources for Wilms Tumor 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....